medigraphic.com

2020, Number 3

<< Back Next >>

Rev Cuba Endoc 2020; 31 (3)

Sarcopenia and related factors in women over 40 years

Fernández PBV, Domínguez AE, Vázquez IB, Acosta CA, Diaz SC, Navarro DDA

Language: Spanish
References: 38
Page: 1-11
PDF size: 432.72 Kb.


ABSTRACT

Introduction: Decreased muscle mass (sarcopenia) and decreased bone mass (osteopenia or osteoporosis) that occur with aging are associated with the increase of fragility and fractures, which affect quality of life and increase mortality. Reports on muscle mass are scarce in our field.
Objectives: Identify the normal reference values of muscle mass in women in the reference area, the frequency of Sarcopenia with the use of the three parameters recommended by the European Consensus, the usefulness of the SARC-F Questionnaire (simple questionnaire for the diagnosis of Sarcopenia) and whether there is a relationship between muscle mass and insulin resistance.
Methods: Descriptive observational study. Muscle mass (bioimpedance and dual X-ray absorcimetry), strength (manual dynamometry) and muscle performance (battery SPPB (short physical performance battery) were determined in 88 women between 45-79 years old, with permanent residence in Plaza de la Revolution municipality (Vedado Polyclinic). The clinical variables were studied. The SARC-F questionnaire (A simple Questionnaire to Rapidly Diagnostic for Sarcopenia) was applied. The fasting blood glucose/insulinemic relation was determined. To determine reference values for decreased muscle mass, 17 healthy women between 40-44 years old were studied. Statistical analysis: Use of cross-tabulations, Kruskall Wallis Test, and Pearson Correlation to identify association between variables, value (p<0.05) X2 test.
Results: Reference value for low muscle mass was <8.33 Kg/m2 per DXA and 15.36 Kg/m2 per bioimpedance. 18% of the group had some degree of sarcopenia that was associated with insulin resistance. The SARF-C questionnaire was not helpful.
Conclusions: The reference value for decreased muscle mass, the presence of sarcopenia and its relationship to insulin resistance were determined.


REFERENCES

  1. Rosenberg I. Summay comments:epidemiological and methodological problems in determing nutricional status of older persons," Adult mayor Journal ClinNutr, 1989;1231-33.

  2. Casati M, Costa AS, Capitanio D, Ponzoni L, Ferri E, Agostini S, et al. The Biological Foundations of Sarcopenia: Established and Promising Markers. Front. Med. 2019;6:184. https://doi.org/10.3389/fmed.2019.00184

  3. Fried LP, Tangen CM. Frailty in older adults: evidence for a phenotype. J. Gerontol A BiolSci Med Sci. 2001;56:146-56.

  4. Canda AS. Puntos de corte de diferrentes parametros antropometricos para el diagnósico de sarcopenia. Nutrición Hospitalaria. 2015;32(2):765-70.

  5. Cruz Jentoft AJ, Pierre Baeyens J, Bauer JM, Boirie Y, Cederholm T. Report Sarcopenia: European consensus on definition and diagnosis. Age and Ageing Advance. 2010;39:412-23.

  6. Rodríguez-Rejón AI, Ruiz-López MD, Wanden-Berghe C, Reyes M. Prevalence and Diagnosis of Sarcopenia in Residential Facilities: A Systematic Review. Artacho Adv Nutr. 2019;10:51-58. https://doi.org/10.1093/advances/nmy058

  7. Morales Larramendi R, Román Montoya AC, Núñez Bourón AI, Lara Lafargue A, Marañón Cardonne M y Castillo Bonne J. Composición corporal: intervalos de lo normal en el estudio mediante bioimpedancia eléctrica de una población de referencia. MEDISAN. 2004;8(4):22-34.

  8. Freire AR, Guerra B, Alvarado J, Guralnk Zunzunegui M. Validiy and reliability of the short physial performance batery in two diverse older adult populations in Quebec and Brazil J, Aging Health. 2012;24(5):863-78.

  9. Hernández-Rodríguez J, Arnold Domínguez Y. Principales elementos a tener en cuenta para el correcto diagnóstico de la sarcopenia. Medisur. 2018[acceso: 15/01/2020];17(1). Disponible en: http://medisur.sld.cu/index.php/medisur/article/view/4073

  10. Garza-González EL, Gallegos-Flores EA, Hernández-Gutiérrez J, Flores-Monsivais JE, Nava-González EJ. Biomarcadores moleculares en la predicción de sarcopenia. Revista de Salud Pública y Nutrición. 2017;16(1):23-32.

  11. Argiles JM, Campos N, López-Pedrosa JM, Rueda R, Rodríguez L. Skeletal muscle regulates metabolism via interrogan crosstalk: roles in health and disease. J Am Med Dir Assoc. 2016;17:789-96.

  12. Parra-Rodríguez L, Szlejf C, García-González AI, Malmstrom TK, Cruz-Arenas E, Rosas-Carrasco O. Adaptación transcultural y validación de la versión en español del cuestionario SARC-F en adultos mayores mexicanos residentes de la comunidad. J Am Med Dir Assoc. 2016;17(12):1142-46.

  13. Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sacopenia at risk for functional outcomes. Journal of Cachexia, Sarcopenia and Muscle. 2016;7:28-36.

  14. Morley J, Cao Li. Rapid screening for sarcopenia. Journal of Cachexia, Sarcopenia and Muscle. 2015;6:312-14.

  15. Tarantino U, Baldi J, Scimeca M, Piccirilli E, Piccioli A, Bonanno E, et al .The role of sarcopenia with and without fracture. Injury. 2016;47Suppl 4:S3-S10.

  16. Rojas Bermúdez Ch, Buckcanan Vargas A, Benavides Jiménez G: Sarcopenia: abordaje integral del adulto mayor. Revista Médica Sinergia. 2019;4(5):24-34.

  17. Anuario Estadístico de Cuba 2016[acceso: 15/01/2020]. Disponible en: http://www.onei.gob.cu/sites/default/files/00_anuario_estadistico_2015.pdf

  18. Acosta Cedeño A, Acosta López L, Díaz Socorro C, Navarro Despaigne D, Cabrera Gámez M. Calidad ósea en adultos de edad mediana. Rev Cubana Endocrinol. 2015[acceso: 18/02/2020];26(2):147-57. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532015000200005&lng=es

  19. García AD, Piñera JA, García A, Bueno Capote C. Fuerza de agarre como predictor de discapacidad en adultos mayores activos. Rev Cubana de Medicina del Deporte y Cultura Física. 2018[acceso: 15/01/2020];13(3). Disponible en: https://instituciones.sld.cu/imd/files/2019/02/Fuerza-de-agarre.pdf

  20. Conesa del Río J, Conesa Gonzalez AI. Antropometría y cálculos energéticos. En: Diabetes Mellitus fundamentos de la terapia dietética para su control metabólico. Capítulo 3, Pág. 17-25. Editorial de Ciencias Médicas, La Habana. 2015.

  21. Hernández Yero JA, Tuero Iglesias A, Vargas González D. Utilidad del índice HOMA-IR con una sola determinación de insulinemia para diagnosticar resistencia insulínica. Rev Cubana Endocrinol. 2011[acceso: 24/02/2020];22(2):69-77. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532011000200002&lng=es

  22. Manzini JL, Declaración de Helsinki: principios éticos para la investigación médica sobre sujetos humanos. Acta bioeth. 2000[acceso: 18/02/2020];6(2):321-34. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S1726-569X2000000200010&lng=es

  23. López-Plaza B, Gómez-Candela C, Bermejo LM. Problemática nutricional relacionada con la fragilidad y la sarcopenia en personas de edad avanzada. Nutr Hosp. 2019;36(No Extra 3):49-52. http://dx.doi.org/10.20960/nh.02809

  24. Sipilä S, Törmäkangas T, Sillanpää E, Aukee P, Kujala UM, Kovanen V, et al. Muscle and bone mass in middle-aged women: role of menopausal status and physical activity. J Cachexia Sarcopenia Muscle. 2020. https://doi.org/10.1002/jcsm.12547

  25. Tosato M, Marzetti E, Cesari M, Savera G, Miller RR, Bernabei R, et al. Measurement of muscle mass in sarcopenia: from imaging to biochemical markers. Aging Clin Exp Res. 2017;29:19-27.

  26. Carson JA, Manolagas S. Effects of sex steroids on bones and muscles: similarities, parallels, and putative interactions in health and disease. Bone. 2015;80: 67-78.

  27. Heymsfield SB, Gonzalez MC, Lu J, Jia G, Zheng Skeletal. Muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia. Proc Nutr Soc. 2015;74:355-66.

  28. Meng-YuehChien, Ta-Yi Huang, Ying-Tai Wu. Prevalence of Sarcopenia Estimated Using a Bioelectrical Impedance Analysis Prediction Equation in Community-Dwelling Elderly People in Taiwan JAGS. 2008:56:1710-15.

  29. Yu SC, Powell A, Khow KS, Visvanathan R. The performance of five bioelectrical impedance analysis prediction equations against dual X-ray absorptiometry in estimating appendicular skeletal muscle mass in an Adult Australian Population. Nutrients. 2016[acceso: 15/01/2020];8(4):189. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848658/pdf/nutrients-08-00189.pdf

  30. Garzón-Orjuela N, Barrera-Perdomo Mel P, Gutiérrez-Sepúlveda MP, Merchán-Chaverra R, et al. Análisis de la composición corporal mediante impedancia bioeléctricaoctopolar en pacientes hospitalizados en Bogotá D.C., Colombia. Estudio piloto. Rev. Fac. Med. 2019;67(3): 239-47.

  31. Cawthon O, Peters K, Michelle D, Shardell M, Robert R, McLean R, et al. Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A BiolSci Med Sci. 2014;69:567-75.

  32. Blumel JE, Salinas C, Danckers L, Tserota K, Ojeda E. Muscle health in Hispanic women. REDLINC VIII. Climacteric VIII Climacteric 2019. https://doi.org/10.1080/13697137.2019.1656186

  33. Landi F, Onder G, Russo A, Liperoti R, Tosato M, Martone AM, et al. Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr 2014; 33: 539-44.

  34. Hui Wang H, Hai S, Cao L, Zhou J, Liu P, Rong Dong BR. Estimation of prevalence of sarcopenia by using a new bioelectrical impedance analysis in Chinese community-dwelling elderly people. BMC Geriatrics. 2016[acceso: 15/01/2020];16:216]. Disponible en: https://bmcgeriatr.biomedcentral.com/track/pdf/10.1186/s12877-016-0386-z

  35. Cruz-Jentoft AJ, Bahato G, Bauer J, Boirie I. Bruyere O and writing group for the European working group on sarcopenia in older people 2 (EWGSOP2), and the extended group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019;48:16-31.

  36. Campodonico I, Bleumel JE, Arteaga E, Vallejo MS, Valdivia MI. Low bone mineral density in middle-aged women: a red flag for sarcopenia. Menopause. 2018;25:324-8.

  37. Shaw SC, Dennison EM, Cooper C. Epidemiology of Sarcopenia: Determinants throughout the Lifecourse. Calcif Tissue Int. 2017;101(3):229-47.

  38. Sánchez Arenales JA. A simple Questionnaire to Rapidly Diagnose Sarcopenia. 2016[acceso: 11/02/2020]. Disponible en: http://biblioteca.galileo.edu/tesario/bitstream/123456789/608/1/2016-T-mgg-006




2020     |     www.medigraphic.com